Urgent.News

What's breaking now, across thousands of outlets.

More in Finance & Markets

Why is United Therapeutics stock surging today?

  • United Therapeutics stock surged 13.7% after Delaware court ruled Liquidia infringed on its patent.
  • Liquidia shares declined significantly, while United Therapeutics peaked at $556.20.
  • Victory strengthens Tyvaso franchise, reduces Liquidia's market access in PH-ILD indication.

More from Wednesday 30 September →